Tirzepatide is a synthetic peptide engineered as a dual agonist of the glucose‑dependent insulinotropic polypeptide (GIP) and GLP‑1 receptors. Supplied as a lyophilized powder for in‑vitro research investigating incretin receptor signaling, biased agonism, and pathway activation under controlled laboratory conditions.
WARNING & DISCLAIMER: This product is intended strictly for laboratory research use only. It is not a drug, food, or cosmetic and should not be used on or by humans or animals. The buyer acknowledges and warrants that they possess the necessary qualifications, licenses, and equipment to handle this material safely and in compliance with all applicable laws. Improper handling, including but not limited to reconstitution, injection, or any form of consumption, is strictly prohibited and done at the buyer's own risk. We assume no liability for misuse of this product.